← Back to Clinical Trials
Recruiting NCT04856059
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Trial Parameters
Condition Fabry Disease
Sponsor University Health Network, Toronto
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-06-15
Completion 2026-12-31
Interventions
Cardiac MRI, ECG/Holter and Blood Biomarkers
Brief Summary
This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.
Eligibility Criteria
Inclusion Criteria: * Fabry disease; * Age ≥ 18 years. Exclusion Criteria: * History of myocardial infarction; * Contraindication to MRI.
Related Trials
NCT06328608
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents
View Trial →
NCT05923788
T1 Mapping in Fabry Disease
View Trial →
NCT04856059
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using M
View Trial →